Swedish Orphan Biovitrum AB Sustainability Reports
Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, manufactures, and markets innovative therapies within haematology, immunology, and specialty care.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300124Y3MQI87PT35
FIGI: BBG001SDX305
14 reports from 2009 to 2025
- Swedish Orphan Biovitrum AB 2025 Annual and Sustainability Report
- Swedish Orphan Biovitrum AB 2024 Annual and Sustainability Report
- Swedish Orphan Biovitrum AB 2023 Annual and Sustainability Report
- Swedish Orphan Biovitrum AB 2022 Annual and Sustainability Report
- Swedish Orphan Biovitrum AB 2021 Annual and Sustainability Report